CAS 325457-99-6

ICA 110381

Description:

ICA 110381, identified by its CAS number 325457-99-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular formula, structure, and physical properties may vary, compounds of this nature are often evaluated for their biological activity, solubility, stability, and interaction with biological targets. Typically, such substances may exhibit properties like moderate to high potency against specific enzymes or receptors, making them candidates for drug development. Additionally, the safety profile, including toxicity and pharmacokinetics, is crucial for assessing their viability as therapeutic agents. Research into ICA 110381 may involve various analytical techniques to determine its efficacy and mechanism of action, as well as its potential side effects. As with any chemical compound, understanding its characteristics is essential for advancing its application in pharmaceuticals or other fields.

Formula: C₁₂H₈Cl₂N₂O

Synonyms:

• 4-CHLOR-N-(6-CHLOR-PYRIDIN-3-YL)-BENZAMID
• ICA-11038
• ICA 110381 (Compound 16)
• ICA 110381
• ICA 110381; ICA110381
• 4-Chloro-N-(6-chloro-pyridin-3-yl)-benzamide
• 4-Chloro-N-(6-chloro-3-pyridinyl)benzamide

ICA 110381

CAS: 325457-99-6

Formula: C₁₂H₈Cl₂N₂O

Purity: 98%

Color and Shape: Solid

Molecular weight: 267.1107

Ref: IN-DA00CMLP

ICA 110381

CAS: 325457-99-6

ICA 110381

Purity: ≥95%

Molecular weight: 267.11g/mol

Ref: 54-BUP06565

ICA 110381

CAS: 325457-99-6

ICA 110381 is a KCNQ2/Q3 potassium channel opener for the treatment of epilepsy

Formula: C₁₂H₈Cl₂N₂O

Purity: 97.72%

Color and Shape: Solid

Molecular weight: 267.11

Ref: TM-T7612

ICA-110381

CAS: 325457-99-6

ICA-110381 is a drug that binds to acetylcholine receptors, which are found in the nervous system. ICA-110381 may be used as an experimental drug for the treatment of Parkinson's disease and Alzheimer's disease. The binding of ICA-110381 to acetylcholine receptors causes an increase in the release of neurotransmitters and an increase in cholinergic activity. The increased release of neurotransmitters may lead to a decrease in symptoms associated with Parkinson's disease or Alzheimer's disease. ICA-110381 also binds to nicotinic acetylcholine receptors and nonselective muscarinic acetylcholine receptors, but does not bind to other neurotransmitter receptors, such as histamine, serotonin, dopamine, GABA, and glutamate receptor.

Formula: C₁₂H₈Cl₂N₂O

Purity: Min. 95%

Molecular weight: 267.11 g/mol

Ref: 3D-ANA45799